NZ191937A - Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position - Google Patents

Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position

Info

Publication number
NZ191937A
NZ191937A NZ191937A NZ19193779A NZ191937A NZ 191937 A NZ191937 A NZ 191937A NZ 191937 A NZ191937 A NZ 191937A NZ 19193779 A NZ19193779 A NZ 19193779A NZ 191937 A NZ191937 A NZ 191937A
Authority
NZ
New Zealand
Prior art keywords
biotics
triazolium
alkyl
ylmethyl group
cephalosporin
Prior art date
Application number
NZ191937A
Other languages
English (en)
Inventor
C O'callaghan
B Ayres
D Livermore
C Newall
D Sutherland
N Weir
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NZ191937A publication Critical patent/NZ191937A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ191937A 1978-10-27 1979-10-26 Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position NZ191937A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842165 1978-10-27
GB7842164 1978-10-27

Publications (1)

Publication Number Publication Date
NZ191937A true NZ191937A (en) 1982-09-07

Family

ID=26269350

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ191937A NZ191937A (en) 1978-10-27 1979-10-26 Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position

Country Status (13)

Country Link
AT (1) AT369009B (xx)
CA (1) CA1130280A (xx)
CH (1) CH644868A5 (xx)
DE (1) DE2943427A1 (xx)
DK (1) DK452679A (xx)
ES (3) ES485441A1 (xx)
FR (1) FR2439786A1 (xx)
GB (1) GB2036724B (xx)
IE (1) IE49100B1 (xx)
IT (1) IT1126819B (xx)
NL (1) NL7907882A (xx)
NZ (1) NZ191937A (xx)
SE (1) SE7908896L (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78245B (xx) * 1980-09-12 1984-09-26 Ciba Geigy Ag
KR860000487B1 (ko) * 1980-09-25 1986-04-30 도야마 가가꾸 고오교 가부시끼가이샤 세팔로스포린의 제조방법
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
EP0062321B1 (en) * 1981-04-03 1989-03-01 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
FR2533216A1 (fr) * 1982-09-22 1984-03-23 Toyama Chemical Co Ltd Nouvelles cephalosporines, et leurs sels
DE3336757A1 (de) * 1983-10-08 1985-04-25 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
EP0214600B1 (en) * 1985-09-03 1992-12-02 Otsuka Kagaku Kabushiki Kaisha Cephalosporin derivatives
US4826834A (en) * 1985-09-27 1989-05-02 Takeda Chemical Industries, Ltd. Cephem compounds
CN86107947A (zh) * 1985-11-22 1987-05-27 藤沢药品工业株式会社 新的头孢烯化合物及其制备方法
KR930009796B1 (ko) * 1991-05-25 1993-10-11 주식회사 대웅제약 신규의 세팔로스포린 및 그의 제조방법
CN114105903B (zh) * 2021-12-16 2023-06-27 河北合佳医药科技集团股份有限公司 一种高纯度去甲基氨噻肟酸乙酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH617703A5 (en) * 1973-12-21 1980-06-13 Glaxo Operations Ltd Process for the preparation of the syn-isomer or of a mixture of syn- and anti-isomers of novel antibiotically active 7 beta -acylamino-ceph-3-em-4-carboxylic acids
GB1496757A (en) * 1973-12-21 1978-01-05 Glaxo Lab Ltd Cephalosporin derivatives
NO750810L (xx) * 1974-03-20 1975-09-23 Hoeganaes Ab
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf

Also Published As

Publication number Publication date
GB2036724A (en) 1980-07-02
DE2943427A1 (de) 1980-05-08
ES485440A1 (es) 1980-07-01
GB2036724B (en) 1983-01-19
SE7908896L (sv) 1980-04-28
CA1130280A (en) 1982-08-24
AT369009B (de) 1982-11-25
IT1126819B (it) 1986-05-21
IT7950680A0 (it) 1979-10-26
NL7907882A (nl) 1980-04-29
DK452679A (da) 1980-04-28
ES485441A1 (es) 1980-07-01
ATA698079A (de) 1982-04-15
FR2439786B1 (xx) 1983-05-20
IE49100B1 (en) 1985-07-24
ES485439A1 (es) 1980-07-01
IE792070L (en) 1980-04-27
FR2439786A1 (fr) 1980-05-23
CH644868A5 (de) 1984-08-31

Similar Documents

Publication Publication Date Title
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
PH14620A (en) Anti-inflammatory 4,5-diaryl-2-nitrodimidazoles
GB2041361B (en) 1,2-dihydro-2-oxo-4-phenyl-3-quinolinecarbonitrile derivatives
AU529068B2 (en) 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
PH15420A (en) 1,2,4-5-tetra-alkyl-4-arylpiperidines
NZ191937A (en) Cephalosporin anti-biotics with a 3-alkyl-1,2,3-triazolium-1-ylmethyl group at the 3-position
GB2067567B (en) 24,24-difluoro-cyclovitamin d3 derivatives
GB2034704B (en) 2,6-daiminonebularines
AU4668779A (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3- benzazepines
IL58525A0 (en) 24.24-dufluoro-25-hydroxycholecalciferol
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
ZA791241B (en) 1.1 diphenylethene derivatives as microbicides
IL56443A0 (en) 2,6-dinitrobenzeneamines
GB2087873B (en) 1,2-dioximes
GB2021108B (en) 6,7 - di - 4 - amino - 2 - quinazolines
PH17142A (en) 6,7-benzomorphans
GB2018769B (en) 2,3-dihydro-4h-1-benzopyran-4-one o-carbamoyl-oximes
GB2072677B (en) 1-n-substituted 3',4'-didehydrokanamycin b derivatives
GB2032431B (en) 2,3 - dimethyl - pent - 4en - aldehyde
ZA792095B (en) 2,6-dialkyl-trifluoromethane-sulphonanilides
IL59681A0 (en) 2,o-dihydro-1,j-bezodioxane derivatives
NZ177260A (en) Cephalosporins with a carboxy group, or derivative thereof, at the 3-position
AU5278479A (en) Perhydro-1,3,-thiazine derivatives
PH14420A (en) 4,5-seco-estrane-3,5,17-trione derivatives
IE841591L (en) Cephalosporin derivatives.